| Typicality: | 0.347 |
| Saliency: | 0.432 |
| over existing therapies | 57 | other |
| on a clinically significant endpoint | 16 | other |
| in effectiveness | 7 | other |
| drug → demonstrate → substantial improvement | 58 |
| drug → demonstrate → substantial improvements | 5 |
| drug → demonstrate → significant improvements | 4 |
| drug → show → significant improvement | 4 |
| drug → demonstrate → significant improvement | 3 |
| drug → show → substantial improvement | 3 |
| negative | neutral | positive |
| 0.007 | 0.211 | 0.782 |
| Raw frequency | 77 |
| Normalized frequency | 0.432 |
| Modifier score | 0.500 |
| Perplexity | 461.108 |